Where healing comes from the heart
Half the world lacks access to essential health services, 100 million still pushed into extreme poverty because of health expenses.
Pharma Segments – Eye Care
ESP offers eye care providers and ambulatory surgery center owners compelling and effective solutions for today’s constantly changing healthcare environment. Utilization of our resources and expertise eliminates the stress of practice management.
We are creating the nation’s leading eyecare services company in both quality and scale by consolidating ophthalmologic and optometric practices and ambulatory surgery centers that are locally dominant and clinically differentiated. We provide a patient centric model that delivers outstanding care and quality outcomes through our providers and staff by leveraging our comprehensive array of best-in-class technology, processes and managerial infrastructure.
According to World Health Organization (WHO) estimates, there are 39 million blind and another 246 million visually impaired people in the world. The burden of blindness in India contributes to nearly one fifth of the global blindness burden. Cataract and refractive errors constitute more than 80% of the blindness and are largely avoidable. Despite gains witnessed in global blindness elimination efforts, the current figures reflect the need for a sustained effort to achieve the goal of elimination of avoidable blindness as envisioned by ‘Vision 2020: The Right to Sight’ by the year 2020.
India has demonstrated a strong commitment towards the reduction of prevalence of overall blindness. India was the first country to initiate the National Program for Control of Blindness (NPCB) in 1976. Despite achieving a high cataract surgical rate of over 5000 surgeries per million population recently, the load of blindness due to cataract is still high. Similarly, refractive errors remain a formidable challenge that needs to be addressed. Due to a rise in risk factors, diabetic retinopathy and glaucoma are also emerging as important conditions that need to be addressed at all levels of health care.
Principally, primary level eye care aims to deliver affordable services to all, irrespective of the socio-economic abilities of individuals. Primary eye care largely refers to a combination of activities encompassing promotive, preventive, therapeutic and rehabilitation services delivered at community level to avert serious sequels resulting in blindness. Since primary eye care is a by-product of larger primary health care, it retains its basic principles of community participation, inter-sectoral co-ordination, use of appropriate technology and equitable distribution of resources.
The components of primary eye care include raising adequate awareness about eye health and the prevention of common eye diseases through health education. Many of the eye conditions such as trachoma, nutritional blindness due to vitamin A deficiency and corneal injuries can be prevented by following simple steps such as -face washing, consuming a vitamin A-rich diet and by taking appropriate care while playing, farming or celebrating festivals like Holi or Diwali. Primary eye care also includes timely detection of common eye diseases such as cataract and refractive errors, the leading causes of visual impairment. Refractive errors can be addressed effectively by ophthalmic assistants through the primary eye care delivery network by provision of spectacles. Screening targeted to identify diabetic retinopathy and glaucoma can also be initiated at this level with provision of essential equipment and adequate training. The patients identified with diseases should be referred to appropriate secondary and tertiary levels for further management. Rehabilitation of people with blindness and low vision can also be carried out at the primary eye care level itself. It is recognized that a majority of cases with avoidable blindness can either be prevented or treated by efficient utilization of existing resources in the community and through creating eye health promotion programs.
In 2004, India adopted ‘Vision 2020: The Right to Sight’ program following a global movement, reiterating the commitment towards elimination of blindness by the year 2020 by establishing 20,000 primary eye care units. These units called ‘vision centers’ act as the first point of interface of the population with skilled, comprehensive eye care service providers. The program has achieved increased public awareness, professional and political commitment for the prevention of blindness. In India, 4000 vision centers in 10th Five year plan and 5000 vision centers in 11th five year plan were to be established but the targets could not be achieved. Recently, the twelfth five year plan (2012-17) has committed to developing 5000 vision centers with revised strategies to achieve the targets.
India, being a vast, heterogeneous country on many fronts needs diverse primary eye care development plans. Currently, primary eye care (PEC) services are delivered through varied models of eye care. It is imperative that these working models be reviewed to assess their strengths and weaknesses and their potential contribution in reducing the blindness burden. This article reports the salient attributes of primary eye care models with the aim of disseminating this information widely for customization of these models in different settings of the country.
Delivering Primary Eye Care Through Various Models
Models for primary eye care reviewed here are primarily divided into two broad categories based on their working operations which may be through fixed facilities or mobile services. Fixed facility primary eye care in primary health care (PHC) centers is commonly provided through fixed or permanent structures available under the government health delivery system. Non-governmental organizations have adopted different models involving stand-alone primary eye care through fixed facility or mobile units.
PEC services through fixed centers
The government of India envisages delivery of primary eye care through the infrastructure and human resources available at primary level under the integrated health care delivery system. The primary eye care facilities are to be located at the community health care (CHC) level (for one lakh population) or PHC level (for a population of 30,000) where there are no surgical specialist services available. ‘Vision 2020: The Right to Sight – India’ has recommended vision centers for every 50,000 population. The Para-Medical Ophthalmic Assistant (PMOA) is the key person who provides eye care services and is trained in conducting refraction and screening of common ocular conditions. The integration of eye services with routine health care service delivery offers the advantage of using existing resources thus ensuring sustainability. Apart from PMOA, the Medical Officer (MO) can provide management for common ocular conditions. The paramedical health workforce can maintain village-wise blind registers thereby ensuring referral for visually impaired persons. Ever since the National Rural Health Mission (NRHM) aiming at architectural correction of health system in India has been launched, the health systems have witnessed great improvement. Community level volunteers like Accredited Social Health Activist (ASHA) workers if appropriately trained and sensitized, could be tapped for channelizing patients to avail primary eye care services in local vicinities. Their work can be supervised by the PMOAs and MOs.
The government of India (GOI) has earmarked INR 50 crores under NPCB for development of vision centers during the12th five year plan. In future, the challenge remains to make the vision centers functional so as to enhance the reach of primary eye care services. The GOI is committed to providing a non-recurring assistance up to Rs one lakh for basic equipment for refraction and screening of other eye diseases, furniture, fixtures etc. Grant-in-aid (GIA) would be used for vision centers in PHCs in government and voluntary sectors.
Outside the public health infrastructure provided by the government of India, many eye institutes are providing community level eye care through stand alone primary eye care centers. LV Prasad Eye Institute (LVPEI) in Andhra Pradesh is providing primary eye care services in fixed facility vision centers through vision technicians. The LVPEI serves a population of nearly 15 million through 95 vision centers. The vision technician (VT) is a high school graduate with one year training in optometry. VTs screen the population for blinding eye conditions, conduct refraction and refer patients to higher level centers for further management. He is supported by Village Health Guardians (VHG) a community level worker selected from the local community for every 5000 population. They identify the patients for cataract surgery at primary eye care level, take them to the base hospital and help them till the follow-ups at the vision centers. VHGs also provide presbyopic spectacles for near vision to the aged population in the community. This is a unique referral model in private eye care institutions linking primary to tertiary level eye care.
Sadguru Netra Chikitsalaya, Chitrakoot (SNCC), Madhya Pradesh also has 24 vision centers to provide primary eye care services for largely a rural population. Aravind Eye Care System (AECS) has 40 vision centers in various districts of south India.
Urban areas are dotted by slums with the dwellers living in disadvantaged conditions. Despite the availability of eye care services in urban areas, the poor population residing in urban slums has no access to it owing to low awareness and financial constraints.
The Community Ophthalmology Department at the ‘Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi is rendering community eye care services through 20 primary eye care (PEC) centers, serving a population of nearly one million in the urban slums of Delhi. More than 40,000 beneficiaries avail the primary eye care services annually through these vision centers. The PEC centers are situated at fixed locations and are managed either by community based organizations (CBOs) or the government sector. This model consists of a team comprising an optometrist and two field workers who visit once or twice a week as per the need of the community in the different slum clusters. The optometrist conducts basic eye examinations along with the prescription of spectacles which are subsidized and arranged at the vision center. Patients screened for cataract surgery or other ocular diseases are referred to the base hospital for free investigations and treatment through the community eye care services program. The other activities include training of local volunteers in primary eye care, health education events in the community and school screening programs to promote the community partnership and awareness about eye care. An almost similar model is adopted by the ‘Kolkata Urban Comprehensive eye care Project (KUCECP), and Mumbai eye care campaign (MECC). Both the programs are implemented in partnership with Sightsavers under Standard Chartered’s ‘Seeing is Believing’ program. KUCECP has 11 vision centers while MECC provide primary eye care services through 15 vision centers.
Mobile primary eye care services
Providing primary eye care services through mobile vans or through tele-ophthalmology is a rapidly emerging strategy for improving eye care delivery in the country and enhancing access to services in difficult to reach areas and rural India.
In some areas, primary eye care is delivered through use of mobile vans. An ophthalmic technician with support staff and a vehicle can be utilized for reaching underserved areas and bridging geographic inequities for eye care services. A range of primary eye care services are currently provided through mobile units depending on sophisticated design, equipment and skilled manpower deputed to provide services. The model is commonly developed for identifying diabetic retinopathy cases among the diabetics. Certain units also provide management of diabetic retinopathy by provision of laser therapy in the mobile vans. Emphasis is laid on an efficient referral system so that all identified cases may be referred for further management at a higher level. The project ‘Nayantara’, Tiupati eye center, NOIDA, Uttar Pradesh, has mobile eye examination and treatment units, which have an inbuilt fundus camera and laser as well. The service through one equipped van is provided in five districts in Western Uttar Pradesh through a network of private practitioners. The retina specialist travels along with the team, which serves as an added invaluable resource. The diabetic retinopathy suspects are generally referred by the local physicians, diabetologists and ophthalmologists who may not have all latest equipment in remote rural areas.
India has been a pioneer in developing and initiating tele-ophthalmology for eye care. This facility can be made available at the fixed center as well as from the mobile vans. Tele-ophthalmology utilizes internet-based information technology, allowing the health care provider patient to have contact with an ophthalmic specialist at base hospital via video conferencing. This helps the patients consult a specialist without travelling and thus bridges the gap of inaccessibility of services. An ophthalmic assistant (OA) is posted at primary eye care centers that examines the patients and feeds information to the ophthalmologist at the base hospital. One of the best examples under government public health system practicing tele-ophthalmology services is that of Tripura, where 40 vision centers are linked to tele-ophthalmology mobile services. The project has decentralized the eye care system and has also reduced the burden of secondary level hospitals.
This model is adopted by Aravind Eye Care System (AECS), Madurai, Sankara Nethralaya, Chennai and many more in different parts of India, mainly by private organizations. Nevertheless, tele-ophthalmology is proving to be a effective model for delivery of primary eye care services to the underserved population where access to an ophthalmologist is a significant obstacle.
Taj products has already enjoyed unchallenged loyalty of our Agents, Distributors and for most the faith of customers. The consistent Market Research and Development has backbone of our endeavors. As a company we are manufacturing and packing most of the products within framework of our group.
One of the largest Active Pharmaceutical Ingredients (API or Bulk Actives) manufacturer in Asia, Taj Pharmaceuticals Ltd; has commercialized over 200 APIs*. Mammoth capabilities and uncompromising product quality underline the core competence of the Company.
The Chemicals business sector focuses on high-quality chemical products for technically demanding applications in R&D and industry. Many years of experience and innovative product solutions make us a preferred partner for laboratories and production.
Taj Group of Companies has launched its food Products division in India an abroad, to augments our strong presence of Quality Products for all the peoples worldwide. We are here committed to establish our brand presence in food Products sectors worldwide.
Taj Generics is one of the leading generic pharmaceutical company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets.
Taj Pharma is one of the largest generic pharmaceutical company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets.
Discover the expert health care deparments offered by Taj Phama Group.
Taj Pharma is one of the largest generic pharmaceutical company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets. You can contact Taj Pharma India’s business by telephone on + 91 022-2637-4592, if you have an enquiry about the company, our healthcare business, or one of our medicines.
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation. Taj Pahrma.
Welcome to the Taj Pharma specialty service of Cardiology where internal medicine is devoted to a collaborative effort, focusing on the treatment and provision of care for the complex cardiac patients. A generic drug is a medication created to be the same as an existing approved brand-name drug.
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
Generic drugs are copies of brand-name drugs that have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety, and strength as the original drug. In other words, their pharmacological effects are exactly the same as those of their brand-name counterparts.
About Taj Pharma
Taj Pharmaceuticals is the global leader in generics and one of the India’s top ten pharmaceutical companies. Taj Pharma India play a leading role in therapeutic areas such as cancer, virology and transplantation. The combined strengths of Taj Pharma generics and pharmaceuticals businesses, coupled with expertise in the emerging genetic sciences, equip us to develop integrated healthcare solutions and therapeutic approaches tailored to individual patients’ needs. Taj Pharmaceutical’s products and services address the entire healthcare spectrum, from screening for genetic risk factors, to preventing, diagnosing and treating disease, and monitoring the treatment response.
Taj Pharma India delivers a unique contribution to better healthcare. Taj Pharma India aim to reduce suffering and improve health and quality of life of people all around the world. At Taj Pharmaceuticals, Taj Pharma India have pursued this mission with patience, dedication, imagination and skill, for over a century. Taj Pharma vision is to develop targeted medicines and diagnostic tools that combine to offer patients, physicians and payers better, safer, more cost-effective healthcare.
Taj Pharmaceuticals Limited is committed to earning the trust of doctors, patients and customers every day. Taj Pharma colleagues worldwide believe that trust is not easily granted, and that is the reason Taj Pharma India focus each day on becoming a champion for Taj Pharma stakeholders.
During the past ten years, Taj Pharmaceuticals Group has been building a new kind of health care company. Throughout Taj Pharma Group (India), there’s a desire to build long-term relationships with Taj Pharma stakeholders based on mutual confidence. This is evident in many ways. Taj Pharma scientists are earning trust through the discovery and development of innovative, science-based medicines and services that improve the health and overall well-being of people around the world. Taj Pharma sales professionals, marketing teams, colleagues working at Taj Pharma plants and others throughout the organization at all levels of responsibility take each day as a fresh opportunity to earn trust.
All of this takes hard work, sharp execution, integrity and transparency on the part of Taj Pharmaceuticals Group colleagues. Taj Pharma global team is working to sustain and expand innovative new treatments. Taj Pharma India’re determined to do Taj Pharma part to increase access to better health care for all people. And, Taj Pharma India is focused on becoming the best in three key strategic areas: people, products and processes.
Taj Pharma India’re beginning to see the results of Taj Pharma efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. From Taj Pharma perspective as a health care company, that means helping people around the world live better and live longer.
Trientine Hydrochloride Cefozone Abirataj Ceftrataj Venoxtaj Colistin Defrataj Clavuxan Tharolax Beprin Etoposide Rabtaj MeslatajDR Pantotaj Glucotaj Merokem Tyronib Ortrex Norvelzo Cocorex Bleomycin Tyronib Ortrex Norvelzo Cocorex Carboplatin Cytarabine Doxorubicin
Copyright ©2020 Taj Pharmaceuticals Limited. All rights reserved. by Taj Pharma Group India.